$574.99
$-3.74 (-0.65%)
End-of-day quote: 05/01/2024
NYSE:TMO

Thermo Fisher Scientific Annual Report

Year Year 2023 2022 2021 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Rev. Revenue
$42.86B $44.92B $39.21B $2.21B $2.63B $3.79B $9.75B $10.50B $9.91B $10.39B $11.56B $12.51B $13.09B $16.89B $16.97B $18.27B $20.92B $24.36B $25.54B $32.22B
GM % Gross Margin %
39.93% 42.30% 50.08% 46.14% 45.89% 41.36% 39.54% 40.08% 39.39% 41.13% 42.10% 42.77% 42.46% 46.17% 45.77% 46.24% 45.59% 44.62% 44.42% 49.69%
OM Operating Margin
17.25% 19.12% 26.08% 11.64% 11.16% 8.44% 10.93% 12.06% 10.76% 12.27% 12.82% 13.05% 13.67% 13.53% 14.75% 15.35% 15.40% 15.93% 16.69% 24.44%
EPS Earnings Per Share
$0.00 $21.55 $23.24 $25.13 $19.55 $12.35 $11.12 $9.49 $8.27 $7.39 $6.96 $5.42 $4.94 $4.16 $3.57 $3.05 $3.16 $2.65 $1.82 $1.55 $1.31
Div. Dividends
$1.36 $1.20 $1.04 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.54 $0.60 $0.60 $0.60 $0.60 $0.60 $0.68 $0.76 $0.88
PR % Payout Ratio %
6.31% 5.16% 4.14% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 10.93% 11.07% 8.62% 8.12% 7.26% 6.32% 6.12% 6.15% 4.50%
Sha. Shares
386.65m 390.51m 394.43m 160.55m 162.48m 416.79m 415.24m 417.97m 409.31m 391.37m 371.38m 357.44m 361.96m 400.47m 399.63m 393.45m 401.31m 402.12m 398.74m 396.67m
OCF Operating Cash Flow
$8.41B $9.15B $9.31B $264.51M $270.90M $405.70M $1.48B $1.42B $1.66B $1.50B $1.69B $2.04B $2.01B $2.62B $2.94B $3.26B $4.01B $4.54B $4.97B $8.29B
FCF Free Cash Flow
$6.65B $6.94B $7.02B $214.52M $227.30M $328.90M $1.31B $1.16B $1.46B $1.24B $1.42B $1.72B $1.75B $2.19B $2.39B $2.74B $3.50B $3.79B $4.05B $6.82B
FCFS Free Cash Flow Per Share
$17.95 $17.63 $17.23 $1.32 $1.41 $1.68 $3.10 $2.76 $3.54 $3.11 $3.76 $4.74 $4.80 $5.50 $6.31 $7.12 $8.85 $9.42 $10.12 $17.21